Sonoma Pharmaceuticals Inc (OCLS):企業の財務・戦略的SWOT分析

◆英語タイトル:Sonoma Pharmaceuticals Inc (OCLS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME13919FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥78,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥117,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for advanced wound management, nursing home and home healthcare, wound and skin care, among others. It offers women’s healthcare products, Microcyn skin and wound care products, Regenacyn advanced scar management hydrogel and animal healthcare, among others. Sonoma develops its products based on shelf-stable microcyn technology platform. The company sells its products through OTC stores. The company operates in the Netherlands and the US. Sonoma is headquartered in Woodstock, Georgia, the US.

Sonoma Pharmaceuticals Inc Key Recent Developments

Mar 31,2021: Sonoma Pharmaceuticals and EMC Pharma Announce an Exclusive Partnership to Expand Commercial Channels of the Microcyn®-based Rx Dermatology and Eye Care Products Nationwide
Mar 04,2021: Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences
Feb 16,2021: Sonoma Pharmaceuticals reports third quarter FY 2021 financial results
Jan 11,2021: Sonoma Pharmaceuticals to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
Dec 10,2020: Sonoma Pharmaceuticals and Crown Laboratories announce an exclusive partnership to launch Microcyn technology-based Anti-Itch Over-the-Counter Products

This comprehensive SWOT profile of Sonoma Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Sonoma Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Sonoma Pharmaceuticals Inc – Key Information
Sonoma Pharmaceuticals Inc – Overview
Sonoma Pharmaceuticals Inc – Key Employees
Sonoma Pharmaceuticals Inc – Key Employee Biographies
Sonoma Pharmaceuticals Inc – Key Operational Heads
Sonoma Pharmaceuticals Inc – Major Products and Services
Sonoma Pharmaceuticals Inc – History
Sonoma Pharmaceuticals Inc – Company Statement
Sonoma Pharmaceuticals Inc – Locations And Subsidiaries
Sonoma Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Sonoma Pharmaceuticals Inc – Business Description
Sonoma Pharmaceuticals Inc – Corporate Strategy
Sonoma Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Sonoma Pharmaceuticals Inc – Strengths
Sonoma Pharmaceuticals Inc – Weaknesses
Sonoma Pharmaceuticals Inc – Opportunities
Sonoma Pharmaceuticals Inc – Threats
Sonoma Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Sonoma Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Sonoma Pharmaceuticals Inc, Key Information
Sonoma Pharmaceuticals Inc, Key Ratios
Sonoma Pharmaceuticals Inc, Share Data
Sonoma Pharmaceuticals Inc, Major Products and Services
Sonoma Pharmaceuticals Inc, History
Sonoma Pharmaceuticals Inc, Key Employees
Sonoma Pharmaceuticals Inc, Key Employee Biographies
Sonoma Pharmaceuticals Inc, Key Operational Heads
Sonoma Pharmaceuticals Inc, Other Locations
Sonoma Pharmaceuticals Inc, Subsidiaries
Sonoma Pharmaceuticals Inc, Key Competitors
Sonoma Pharmaceuticals Inc, SWOT Analysis
Sonoma Pharmaceuticals Inc, Ratios based on current share price
Sonoma Pharmaceuticals Inc, Annual Ratios
Sonoma Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Sonoma Pharmaceuticals Inc (OCLS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hanesbrands Inc (HBI):企業の財務・戦略的SWOT分析
    Hanesbrands Inc (HBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • US WorldMeds LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary US WorldMeds LLC (US WorldMeds) is a specialty pharmaceutical company that develops, licenses and markets healthcare products to improve lives of patients with challenging conditions and unmet medical needs. The company’s products comprise apokyn, myobloc and revonto. Its apokyn is used for …
  • Sophiris Bio Inc (SPHS):製薬・医療:M&Aディール及び事業提携情報
    Summary Sophiris Bio Inc (Sophiris) is a clinical stage bio-pharmaceutical company, which focuses on developing products for the treatment of urological diseases. Sophiris lead drug candidate, PRX302 is under late stage development for the treatment of lower urinary tract symptoms of benign prostati …
  • Rising Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rising Pharmaceuticals Inc (Rising Pharma), a subsidiary of Aceto Corp, is a manufacturer and distributor of generic prescription pharmaceutical products. The company’s products include amiloride hydrochloride, benztropine, anastrozole, carisoprodol, codeine phosphate, cetirizine hydrochlori …
  • PT Sinar Mas Agro Resources and Technology Tbk (SMAR):企業の財務・戦略的SWOT分析
    PT Sinar Mas Agro Resources and Technology Tbk (SMAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • Topas Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Topas Therapeutics GmbH (Topas Therapeutics) is a biotechnological company that designs and develops nanoparticle products loaded with antigenic peptides. The company’s pre-clinical pipeline categories are used in the treatment of allergies, immune mediated diseases, autoimmune diseases, and …
  • Imvescor Restaurant Group Inc:戦略・SWOT・企業財務分析
    Imvescor Restaurant Group Inc - Strategy, SWOT and Corporate Finance Report Summary Imvescor Restaurant Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Paliburg Holdings Limited:戦略・SWOT・企業財務分析
    Paliburg Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Paliburg Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Lanco Infratech Ltd (LITL):企業の財務・戦略的SWOT分析
    Lanco Infratech Ltd (LITL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • GCL-Poly Energy Holdings Ltd (3800)-エネルギー分野:企業M&A・提携分析
    Summary GCL-Poly Energy Holdings Ltd. (GCL) is a provider of solar photovoltaic (PV) material and professional PV system solutions. The company produces and supplies high-quality solar grade and semiconductor grade polysilicon raw materials and silicon wafers to companies operating in the solar indu …
  • Abu Dhabi National Oil Co:企業の戦略的SWOT分析
    Abu Dhabi National Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • FMC Corp (FMC):企業の財務・戦略的SWOT分析
    FMC Corp (FMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • NuSirt Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NuSirt Biopharma Inc (NuSirt Sciences) develops a technology platform that combines natural compounds with various pharmaceutical agents to prevent and treat chronic diseases resulting from over-nutrition and aging. Its technology platform focuses on activating sirtuin pathways through the a …
  • Automatic Data Processing, Inc.:企業の戦略・SWOT・財務分析
    Automatic Data Processing, Inc. - Strategy, SWOT and Corporate Finance Report Summary Automatic Data Processing, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Hutchison Telecommunications Hong Kong Holdings Limited (215):企業の財務・戦略的SWOT分析
    Hutchison Telecommunications Hong Kong Holdings Limited (215) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the co …
  • TTM Technologies Inc:企業の戦略・SWOT・財務分析
    TTM Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary TTM Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Fichtner GmbH & Co KG:企業の戦略的SWOT分析
    Fichtner GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cross Country Healthcare Inc (CCRN):企業の財務・戦略的SWOT分析
    Cross Country Healthcare Inc (CCRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Annaly Capital Management Inc:企業の戦略・SWOT・財務情報
    Annaly Capital Management Inc - Strategy, SWOT and Corporate Finance Report Summary Annaly Capital Management Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Mologen AG (MGN):企業の財務・戦略的SWOT分析
    Summary Mologen AG (Mologen) is a biotechnology company that offers research and clinical development of novel drugs, immunotherapies and active ingredients. The company develops various pipeline products such as MGN1703, MGN1601, MGN1404, MGN1331 and MGN1333. It uses proprietary platform technologi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆